Clinical characteristics and outcomes of juvenile and adult dermatomyositis

Journal of Korean Medical Science

Volumn 24, Issue 4, 2009, Pages 715-721

  Na, Sang Jun ^a,b   Kim, Seung Min ^b   Sunwoo, Il Nam ^b   Choi, Young Chul ^b  

^a Konyang University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adult dermatomyositis; Clinical characteristics; Juvenile dermatomyositis; Outcomes

Indexed keywords

ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MINERALIZATION; CASE REPORT; DERMATOMYOSITIS; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MUSCLE WEAKNESS; ONSET AGE; PROGNOSIS; RASH; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTI-INFLAMMATORY AGENTS; CALCIFICATION, PHYSIOLOGIC; DERMATOMYOSITIS; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PREDNISOLONE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 70350741400     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.4.715     Document Type: Article

References (40)

1. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL. Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol 1996; 34: 824-9.
2. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computerassisted analysis of ninety-two cases. Arthritis Rheum 1985; 28: 249-55.
3. Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17: 1329-34.
4. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995; 34: 732-6.
5. Kaipiainen-Seppanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996; 14: 441-4.
6. Callen JP. Dermatomyositis: diagnosis, evaluation and management. Minerva Med 2002; 93: 157-67.
7. Huemer C, Kitson H, Malleson PN, Sanderson S, Huemer M, Cabral DA, Chanoine JP, Petty RE. Lipodystrophy in patients with juvenile dermatomyositis-evaluation of clinical and metabolic abnormalities. J Rheumatol 2001; 28: 610-5.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
10. Mastaglia FL, Ojeda VJ. Inflammatory myopathies: Part 1. Ann Neurol 1985; 17: 215-27.
11. Mastaglia FL, Ojeda VJ. Inflammatory myopathies: Part 2. Ann Neurol 1985; 17: 317-23.
12. Hiketa T, Matsumoto Y, Ohashi M, Sasaki R. Juvenile dermatomyositis: a statistical study of 114 patients with dermatomyositis. J Dermatol 1992; 19: 470-6.
13. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27: 407-25.
14. Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol 1994; 6: 595-601.
15. Spiera R, Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 1998; 10: 556-61.
16. Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol 2006; 24: 363-73.
17. Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, Chen EH. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 2000; 43: 2368-77.
18. King TE. Interstitial Lung Disease. In: Braunwald E, Fauci AS, Kasper DL, Hauser S, Longo DL, Jameson JL, eds, Harrison's Princile of Internal Medicine, 15th ed. New York: McGraw-Hill, 2001; 1499-505.
19. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357: 96-100.
20. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998; 25: 1336-43.
21. Pautas E, Cherin P, Piette JC, Pelletier S, Wechsler B, Cabane J, Herson S. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Clin Exp Rheumatol 2000; 18: 241-4.
22. Alexander S, Forman L. Dermatomyositis and carcinoma. Br J Dermatol 1968; 80: 86-9.
23. Curtis AC, Blaylock HC, Harrell ER Jr. Malignant lesions associated with dermatomyositis. J Am Med Assoc 1952; 150: 844-6.
24. Whitmore SE, Rosenshein NB, Provost TT. Ovarian cancer in patients with dermatomyositis. Medicine (Baltimore) 1994; 73: 153-60.
25. Peng JC, Sheen TS, Hsu MM. Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Arch Otolaryngol Head Neck Surg 1995; 121: 1298-301.
26. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255-86.
27. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993; 52: 857-61.
28. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, MacNeil I, Momy JA, Avery G, Feldman BM. Medium-and longterm functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 541-9.
29. Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep 2005; 7: 441-6.
30. Tabarki B, Ponsot G, Prieur AM, Tardieu M. Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 1998; 2: 205-11.
31. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, Pilkington CA; Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford) 2006; 45: 1255-60.
32. Uthman I, Vazquez-Abad D, Senecal JL. Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum 1996; 26: 447-58.
33. Lundberg I, Nennesmo I, Hedfors E. A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies. Semin Arthritis Rheum 1992; 22: 127-38.
34. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996; 14: 263-74.
35. Henriksson KG, Lindvall B. Polymyositis and dermatomyositis 1990--diagnosis, treatment and prognosis. Prog Neurobiol 1990; 35: 181-93.
36. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-7.
37. Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, Song YW. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44: 1282-6.
38. Hochberg MC, Lopez-Acuna D, Gittelsohn AM. Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum 1983; 26: 1465-71.
39. Ramirez G, Asherson RA, Khamashta MA, Cervera R, D'Cruz D, Hughes GR. Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. Semin Arthritis Rheum 1990; 20: 114-20.
40. Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U, Courtois H, Devulder B. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999; 78: 139-47.